SH

SHINIL PHARMACEUTICAL CO., LTD.

012790 | KO

Overview

Corporate Details

ISIN(s):
KR7012790002
LEI:
Country:
South Korea
Address:
충북 충주시 앙성면 본평리 산 5-1, 충주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 841.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 876.9 KB
2025-03-24 00:00
AGM Information
정기주주총회결과
Korean 22.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 17.2 KB
2025-03-14 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.8 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 87.0 KB
2025-03-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.3 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 740.8 KB
2024-08-09 00:00
Interim / Quarterly Report
반기보고서 (2024.06)
Korean 738.9 KB
2024-06-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 788.8 KB

Automate Your Workflow. Get a real-time feed of all SHINIL PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SHINIL PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SHINIL PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cuorips Inc. Logo
Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.
Japan
4894
Cuprina Holdings (Cayman) LTD Logo
Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.
United States of America
CUPR
Curanex Pharmaceuticals Inc Logo
Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.
United States of America
CURX
Curasight A/S Logo
Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.
Denmark
CURAS
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany
CVAC
CureVac N.V. Logo
Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.
United States of America
CVAC
CURIS INC Logo
Biotech developing innovative cancer therapeutics for hematologic malignancies.
United States of America
CRIS
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea
372320
CYBIN INC. Logo
A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.
United States of America
CYBN
Cyclerion Therapeutics, Inc. Logo
Developing personalized therapy for TRD with a biofeedback device and anesthetics.
United States of America
CYCN

Talk to a Data Expert

Have a question? We'll get back to you promptly.